Anatomical Femoral Stem in Total Hip Arthroplasty

• Conditions: Patient Compliance; Patient Satisfaction
• Interventions: Device: Short anatomical femoral stem in THR

• Registration Number: NCT04243980
• Lead Sponsor: HaEmek Medical Center, Israel

Brief Summary

A study that detect the femoral anteversion after total hip arthroplasty using short anatomical femoral stem compared to the contrast side

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-01
• Study First Submitted: 2020-01-23
• Study First Submitted QC: 2020-01-26
• Last Update Submitted: 2020-01-26
• Study First Posted: 2020-01-28
• Last Update Posted: 2020-01-28
• Study Start: 2020-02-01
• Primary Completion: 2021-01-01
• Study Completion: 2022-01-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• age 18-90
• patients who had THR as an elective surgery
• patients who had THR with short femoral anatomical stem

Exclusion Criteria

• severe osteoporosis with Dorr C classification
• s/p bilateral hip arthroplasty
• non-complaint patients
• revision surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Group 1	Short anatomical femoral stem in THR	Patients after total hip arthroplasty with short femoral stem

Primary Outcome Measures

Name	Time	Method
Femoral anteversion	Post-Operatively, through study completion, an average of 2 years	comparing femoral anteversion after THR using CT scan

Secondary Outcome Measures

Name	Time	Method
Harris Hip Score	6 weeks, 3 month, 6 month post-operative	The HHS is a physician-completed instrument that consists of subscales for pain severity (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 0-4 points), and range of motion (2 items, 0-5 points).; Where a score \< 70 indicating a poor result and those of 90-100 indicating an excellent result